Over the past 12 months, 0 insiders at DICE Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on DICE: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 23 | Northpond Ventures Ii, LpTenPercentOwner | SELL | 1.97M | $46.50 | $91.6M |
| Jun 1, 23 | John R. JacobsenCSO | SELL | 14.3K | $31.24 | $434K |
| May 5, 23 | Richard H SchellerDirector | SELL | 84.1K | $38.51 | $3.2M |
| May 3, 23 | Kevin JudiceCEO | SELL | 13.7K | $36.50 | $500K |
| May 3, 23 | Scott M. RobertsonCFO & CBO | SELL | 18.8K | $36.55 | $685K |
| May 3, 23 | Lu TimothyCMO | SELL | 10.0K | $36.54 | $365K |
| Apr 18, 23 | John R. JacobsenCSO | SELL | 16.4K | $30.08 | $493K |
| Mar 31, 23 | John R. JacobsenCSO | SELL | 773 | $30.00 | $23K |
| Mar 30, 23 | Ra Capital Nexus Fund Ii, L.p.Director,TenPercentOwner | BUY | 196.0K | $28.74 | $5.6M |
| Mar 29, 23 | John R. JacobsenCSO | SELL | 1.1K | $30.00 | $33K |
| Mar 29, 23 | Ra Capital Nexus Fund Ii, L.p.Director,TenPercentOwner | BUY | 66.4K | $29.38 | $1.9M |
| Mar 28, 23 | John R. JacobsenCSO | SELL | 500 | $30.09 | $15K |
| Mar 28, 23 | Ra Capital Nexus Fund Ii, L.p.Director,TenPercentOwner | BUY | 246.8K | $29.24 | $7.2M |
| Mar 27, 23 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 151.1K | $27.48 | $4.2M |
| Mar 24, 23 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 192.3K | $26.87 | $5.2M |
| Mar 23, 23 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 155.1K | $26.67 | $4.1M |
| Mar 17, 23 | James Paul ScopaDirector | SELL | 10.0K | $29.05 | $291K |
| Oct 17, 22 | Peter KolchinskyDirector,TenPercentOwner | BUY | 1.64M | $36.50 | $59.9M |
| Sep 17, 21 | Peter KolchinskyDirector,TenPercentOwner | BUY | 1.32M | $17.00 | $22.5M |
| Sep 17, 21 | Michael P. RubinTenPercentOwner | BUY | 235.0K | $17.00 | $4.0M |
| Sep 15, 21 | James Paul ScopaDirector | BUY | 6.0K | $17.00 | $102K |
Over the past 12 months, insiders at DICE Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on DICE, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market DICE insider purchase in our data was $59.9M by Peter Kolchinsky, Director,TenPercentOwner, filed on Oct 17, 22.
0 different insiders at DICE Therapeutics, Inc. filed open-market SEC Form 4 transactions on DICE over the last 12 months.
InsiderTape plots every DICE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every DICE Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →